Applied Clinical Trials
July 01, 2012
News
21
7
Cost inefficiencies in drug development are a major focus of discussion, especially with the many financial impacts affecting the pharmaceutical sponsors.
July 01, 2012
Business News
21
7
Industry news focusing on the people and organizations who work in the clinical trials profession.
July 01, 2012
21
7
The percentage of source document verification coverage has been decreasing slightly over the past four years. Therefore, the amount of on-site time required by site monitors should also start decreasing.
July 01, 2012
View from Brussels
21
7
Proposed rule changes on public information in Europe never make it to fruition.
July 01, 2012
Feature Article
21
7
Biosimilars are a steadily growing new field of biopharmaceutical development and clinical research.
July 01, 2012
Feature Article
21
7
Analysis suggests age, condition, and treatment satisfaction have most significant effect on participation.
July 01, 2012
News
21
7
In August last year, the FDA came out with its Guidance for Industry Oversight of Clinical Investigations-a Risk-Based Approach to Monitoring. Sponsors and CROs alike are still examining the document and discussing how best to move forward.
July 01, 2012
News
21
7
Criticisms of the pharmaceutical industry's real motives for undertaking post-marketing studies have been made by a special report in the British Medical Journal.
July 01, 2012
News
21
7
The main result of the Supreme Court decision upholding the Affordable Care Act (ACA) is that it ends all the rampant speculation and uncertainty about the future shape of the US healthcare system.
July 01, 2012
CTI Insights
21
7
Despite their growing role, little benchmark management data, until now, existed on global study monitors.
July 01, 2012
A Closing Thought
21
7
Prior to initiating a trial with ED sites, three factors must be considered in order to achieve success.
July 01, 2012
News
21
7
It's hard enough to conduct clinical trials for experimental medicines, but it can be even more difficult when patients already have access to the medicine outside the research setting.
July 01, 2012
Issue PDF
21
7
Regulatory: Developing Biosimilars for a Global Market Subject Recruitment: Patient Interest in Clinical Trial Referral CRO/Sponsor: Functional Service Provider Model Also in this issue: Proposed Rule Changes in Europe Global Study Monitors Benchmarks Emergency Department Trials